Afuco™ Anti-Human CDH11 ADCC Therapeutic Antibody (SDP051), ADCC Enhanced
Anti-CDH11 ADCC Enhanced Antibody (SDP051) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a humanized monoclonal antibody to Cadherin-11, which acts as an "adhesive" between cells. Changes in Cad-11 interactions can induce cells to produce proteins that influence the cellular environment. Results from the Phase 1 trial show that SDP051 is safe and well-tolerated at doses up to 10 mg/kg per day with no evidence of significant side effects.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-142CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CDH11 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|